标题
Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic
作者
关键词
-
出版物
CLINICAL INFECTIOUS DISEASES
Volume 61, Issue 8, Pages 1315-1321
出版商
Oxford University Press (OUP)
发表日期
2015-07-18
DOI
10.1093/cid/civ501
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe
- (2015) Daniel F. Sahm et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Tedizolid: A new oxazolidinone antimicrobial
- (2014) J. J. Kisgen et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Platelet Profile in Patients with Acute Bacterial Skin and Skin Structure Infections Receiving Tedizolid or Linezolid: Findings from the Phase 3 ESTABLISH Clinical Trials
- (2014) Thomas P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections
- (2014) Andrew F. Shorr et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
- (2014) Dennis L. Stevens et al. CLINICAL INFECTIOUS DISEASES
- In vitro antimicrobial activity of the novel oxazolidinone tedizolid and comparator agents against Staphylococcus aureus and linezolid-resistant Gram-positive pathogens: a multicentre study in China
- (2014) Hongbin Chen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial
- (2014) Gregory J Moran et al. LANCET INFECTIOUS DISEASES
- Early Experience with Tedizolid: Clinical Efficacy, Pharmacodynamics, and Resistance
- (2014) Jeffrey M. Rybak et al. PHARMACOTHERAPY
- In Vitro,In Vivo, and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions
- (2013) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tedizolid Phosphate for the Management of Acute Bacterial Skin and Skin Structure Infections: Efficacy Summary
- (2013) W. O'Riordan et al. CLINICAL INFECTIOUS DISEASES
- Use of Pharmacokinetic/Pharmacodynamic Systems Analyses to Inform Dose Selection of Tedizolid Phosphate
- (2013) Thomas P. Lodise et al. CLINICAL INFECTIOUS DISEASES
- Tedizolid for the Management of Human Infections: In Vitro Characteristics
- (2013) Jeffrey B. Locke et al. CLINICAL INFECTIOUS DISEASES
- Tedizolid: A Novel Oxazolidinone for Gram-Positive Infections
- (2013) Robert C. Moellering CLINICAL INFECTIOUS DISEASES
- Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2013) Philippe Prokocimer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug
- (2013) Shawn D. Flanagan et al. PHARMACOTHERAPY
- Activity of Tedizolid Phosphate (TR-701) in Murine Models of Infection with Penicillin-Resistant and Penicillin-Sensitive Streptococcus pneumoniae
- (2012) Sunghak Choi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections
- (2012) Philippe Prokocimer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers
- (2012) Seth T. Housman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Pharmacodynamics of the New Oxazolidinone Tedizolid Phosphate and Linezolid in a Neutropenic Murine Staphylococcus aureus Pneumonia Model
- (2012) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeIn VivoEfficacies of Epithelial Lining Fluid Exposures of Tedizolid, Linezolid, and Vancomycin for Methicillin-Resistant Staphylococcus aureus in a Mouse Pneumonia Model
- (2012) Pamela R. Tessier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Chemistry of Peptidyltransferase Center-Targeted Antibiotics: Enzymatic Resistance and Approaches to Countering Resistance
- (2011) Kevin P. McCusker et al. ACS Chemical Biology
- The oxazolidinones: past, present, and future
- (2011) Karen Joy Shaw et al. Annals of the New York Academy of Sciences
- In VivoPharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model
- (2011) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
- (2011) Katherine S. Long et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations
- (2010) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections
- (2010) P. Prokocimer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges
- (2010) S. D. Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent
- (2009) R. Schaadt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci
- (2009) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines
- (2009) S. Lemaire et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
- (2008) K. J. Shaw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started